BIOMAT Database Logo BIOMAT Database Logo

Prostate-specific antigen following radiation therapy. 1996

R E Peschel

UI MeSH Term Description Entries
D008297 Male Males
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D017430 Prostate-Specific Antigen A glycoprotein that is a kallikrein-like serine proteinase and an esterase, produced by epithelial cells of both normal and malignant prostate tissue. It is an important marker for the diagnosis of prostate cancer. Kallikrein hK3,gamma-Seminoprotein,hK3 Kallikrein,Prostate Specific Antigen,Semenogelase,Seminin,Kallikrein, hK3,gamma Seminoprotein

Related Publications

R E Peschel
Prostate-specific antigen bounce following stereotactic body radiation therapy for prostate cancer.
January 2014, Frontiers in oncology,
R E Peschel
Determinants of prostate cancer specific survival following radiation therapy during the prostate specific antigen era.
December 2003, The Journal of urology,
R E Peschel
Australian prostate-specific antigen outcome and toxicity following radiation therapy for localized prostate cancer.
December 2003, Australasian radiology,
R E Peschel
Effect of adjuvant radiation therapy on prostate specific antigen following radical prostatectomy.
June 1990, The Journal of urology,
R E Peschel
Overall survival after prostate-specific-antigen-detected recurrence following conformal radiation therapy.
October 2000, International journal of radiation oncology, biology, physics,
R E Peschel
Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: clinical observations.
January 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
R E Peschel
Adjuvant radiation therapy in patients with detectable prostate specific antigen following radical prostatectomy.
March 1991, The Journal of urology,
R E Peschel
Prostate-specific antigen nadir and cancer-specific mortality following hormonal therapy for prostate-specific antigen failure.
September 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
R E Peschel
Prostate-specific antigen and external beam radiation therapy in prostate cancer.
January 1991, Cancer,
R E Peschel
Prostate-specific antigen and radiation therapy for clinically localized prostate cancer.
May 1995, International journal of radiation oncology, biology, physics,
Copied contents to your clipboard!